Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management

Michela Starace,Matilde Iorizzo,Andrea Sechi,Aurora Maria Alessandrini, Miriam Carpanese,Francesca Bruni,Giulio Vara,Zoe Apalla,Daniel Asz-Sigall,Stefania Barruscotti,Francisco Camacho,Isabella Doche, Bruna Duque Estrada,Rachita Dhurat, Maria Fernanda Gavazzoni,Ramon Grimalt,Matthew Harries,Dimitrios Ioannidis,Amy McMichael,Daniel Fernandes Melo, Rui Oliveira,Yuliya Ovcharenko,Rodrigo Pirmez,Yuval Ramot,Lidia Rudnicka,Jerry Shapiro,Tatiana Silyuk,Rodney Sinclair,Antonella Tosti,Sergio Vano-Galvan,Bianca Maria Piraccini

JAAD International（2021）

引用 36|浏览1

暂无评分

摘要

The severity of postviral telogen effluvium observed in patients with a history of COVID-19 infection may be influenced by COVID-19 severity. We identified early-onset (<4 weeks) and late-onset (>12 weeks) telogen effluvium.

查看译文

关键词

COVID-19,hair loss,hair shedding,multicentric study,SARS-CoV-2,scalp allodynia,telogen effluvium,trichodynia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要